New York, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Attorney Advertising
Amparo Law Firm PLLC, through its Amparo Investor Rights practice, is investigating whether the announced price is the best price MidCap Financial Investment Corporation (MFIC) shareholders could obtain, whether the board ran a sale process designed to get it, and whether shareholders may have claims for additional value. We are also investigating whether the proxy statement gives you every fact Section 14(a) requires so you can judge that price before you vote. The proposed merger is with Ares Capital Corporation.
MFIC shareholders: click here to learn more about your rights and options at no cost or obligation.
THE QUESTION BEHIND THE PREMIUM
Ares Capital Corporation, a publicly traded business development company externally managed by a subsidiary of Ares Management Corporation has agreed to acquire MidCap Financial Investment for $10.88 per fully diluted MFIC share, made up of about $1.21 per share in cash, and the company describes the premium as approximately 30.1% above MFIC's closing share price on October 26, 2026, the last trading day before the announcement, and the company gives the deal value as total enterprise value of approximately $2.6 billion.
A premium over a recent trading price does not by itself show that shareholders are getting the best price. Before you vote, you should be able to see how the board chose this buyer and this number, what other options it weighed, and what its financial advisors concluded. Those details usually appear in the proxy statement, which has not been filed yet.
THE DEAL AT A GLANCE
- Buyer: Ares Capital Corporation, a publicly traded business development company externally managed by a subsidiary of Ares Management Corporation
- Price: $10.88 per fully diluted MFIC share, made up of about $1.21 per share in cash
- Premium: About 30.1% (company-stated)
- Deal value: About $2.6 billion enterprise value (company-stated)
- Announced: October 27, 2026
- Shareholder vote: Not yet scheduled
- Expected closing: First half of 2027
WHAT WE ARE INVESTIGATING
- The price. Whether the announced price is the best price shareholders could obtain, and whether shareholders may have claims for additional value.
- The sale process. How the board ran the sale process and whether it looked for other buyers.
- The stock component. How the stock shareholders would receive is valued, and whether the exchange ratio reflects what their shares are worth.
- The advisors. The financial advisors' fees and any ties they have to the buyer.
- The disclosures. Whether the proxy statement gives you every fact Section 14(a) requires so you can judge that price before you vote.
WHY TIMING MATTERS
Shareholders usually have the most options before a deal goes to a vote. the Special Committee of MFIC independent directors unanimously recommended the deal, and Apollo Principal Holdings A, L.P. and MidCap Financial Trust, affiliates of Apollo Management that together own 5.2% of MFIC's outstanding common stock, have entered into voting and support agreements with Ares Capital. The shareholder vote has not yet been scheduled.
TALK TO US ABOUT YOUR MFIC SHARES
amparoinvestorrights.com/actions/midcap-financial-investment-corporation/
or call (888) 577-7817
No cost to speak with us. We speak English and Spanish.
You do not need to buy or sell shares to contact us.
QUESTIONS SHAREHOLDERS ASK
Does it cost anything?
Amparo Investor Rights handles shareholder matters on a contingency basis. You pay no fees or costs unless there is a recovery.
Is contacting you confidential?
We keep your communications with us confidential. Contacting the firm does not create an attorney-client relationship.
What happens next?
An attorney reviews your information and follows up with you.
ABOUT THE ATTORNEY
The practice is led by Bob Amirian, Esq., Founding Partner of Amparo Law Firm. A graduate of Georgetown University Law Center and a summa cum laude graduate of UCLA, he served as a law clerk to Chief Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit and practiced at Venable LLP.
About Amparo Investor Rights: Amparo Investor Rights is the securities practice of Amparo Law Firm PLLC, a New York law firm that represents investors in shareholder investigations, merger disclosure claims and securities litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome. Contacting the firm does not create an attorney-client relationship. Responsible attorney: Bob Amirian, Esq., Amparo Law Firm PLLC, 40 Wall Street, 28th Floor, New York, NY 10005, (888) 577-7817. Amparo Law Firm PLLC is licensed to practice law in New York, California, Texas, and the District of Columbia.
Contact: Amparo Investor Rights, (888) 577-7817, intake@amparolawfirm.com
Amparo Investor Rights, (888) 577-7817
